In Arizona, Axolotl Biologix, a regenerative human cell and tissue medical technologies company, entered into an exclusive worldwide license agreement with Protein Genomics, Inc., an R&D company focused on biopolymers for applications in wound healing and tissue regeneration. The license agreement allows Axolotl Biologix to use Protein Genomics’ patents and manufacturing knowledge for a biomimetic skin substitute made from biomaterial called Elastropin. This will help grow and expand Axolotl Biologix’s burn, surgical and wound treatment products. Axolotl Biologix is also acquiring Protein Genomics’ research laboratory in Flagstaff as part of the agreement, and gave a heads up that they plan on filing three new patents in the very near future, so stay tuned.
Home Biomaterials Axolotl Biologix Acquires Protein Genomics’ Research Lab and Signs License Agreement
Latest article
Green beans: Brazil’s Cellva uses biotech to convert coffee waste into cocoa substitute
In Brazil, a São Paulo-based biotech startup is converting coffee waste into cocoa substitute in an effort to address shortages, high prices, and large...
Artist Daniel Arsham creates limited edition poker sets out of ceramic and linen
In New York, contemporary artist Daniel Arsham has crafted ceramic poker chips and linen playing cards to explore the game’s “duality,” in that it...
Bioplastics get the glam treatment from Mo. Na Gems
In New York, jewelry brand Mo.Na Gems is using potato starch-based plastics to mimic gemstones and, reportedly, gaining a following in the New York...